History

Twenty Years of Saving and Improving Lives

ppta-20-yearsIn 2012, PPTA celebrated its 20th Anniversary. In two short decades, it has become recognized as a global leader and authoritative voice of the plasma protein therapeutics industry.

PPTA represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma.

The Associations originally formed as the International Plasma Products Industry Association (IPPIA) in 1992. The organization started a European division in 1994, the European Association of the Plasma Products Industry (EAPPI) and in 1998 formed IPPIA in North America. In 2000, EAPPI and IPPIA merged to form the Plasma Protein Therapeutics Association (PPTA). In 2002, PPTA merged with the American Blood Resources Association (ABRA) and added the Source Division to represent collectors.

PPTA’s accomplishments demonstrate continued leadership and innovation. The Association’s dedication to quality, safety and standards has resulted in no reported viral transmissions for two decades. In addition, the Association has established constructive dialog and relationships with regulators, policymakers and patient organizations throughout the world and in doing so, has become a trusted and reliable leader in combatting rare diseases. Finally, PPTA has maintained an unwavering commitment to advocacy efforts that supports patient access to care.

Timeline

1992-Originally formed as the International Plasma Products Industry Association (IPPIA)

1994—European Association of the Plasma Products Industry formed (EAPPI)

1998—IPPIA, North America Division formed

2000—EAPPI and IPPIA merge to form PPTA

2002—PPTA merges with the American Blood Resources Association (ABRA)

2002—PPTA Source Division formed to represent plasma collectors

Click images to enlarge.